The Training Sequence Myth: What These Studies Really Show

Someone looked at their search results, found two loosely exercise-adjacent studies, and decided they constituted a training protocol. They don't. Here's what actually happened — and why it matters more than you might think.

The Pitch

The framing goes like this: there's an optimal order for combining resistance training and sprint intervals, and exercise produces a kidney-protecting hormone called irisin. Stack these findings together and you supposedly have a science-backed protocol for muscle development and metabolic health.

This is what it looks like when a conclusion is written before the evidence is read. The two studies this claim rests on don't communicate with each other. They were designed for completely different populations, used different methodologies, and answered completely different questions. Forcing them into a single narrative requires ignoring almost everything specific about both of them.

Study 1: The Judo RCT

The first study, published in the Journal of Sports Science & Medicine, is a 6-week randomized controlled trial. Twenty-four male judo athletes were assigned to one of two groups: one trained sprint intervals before resistance work, the other did resistance work first. Researchers measured lower-body power, strength, and sport-specific fitness attributes at baseline and post-training.

The finding: sprint-first sequencing produced better lower-body power gains over the 6-week block. This is a real result from a real RCT, and the study is well-designed for what it was trying to answer. The problem is what it was trying to answer, and for whom.

Why the finding doesn't leave the dojo

• N=24 is too small for confident conclusions. Small trials have low statistical power and elevated false positive rates. Results at this sample size routinely fail to replicate. A finding that holds for 24 people may look completely different in 240.
• Judo athletes are not a general population. These are trained competitive fighters with sport-specific movement patterns, training histories, and neuromuscular adaptations. The stimuli that optimize lower-body power for throws and takedowns are not the same stimuli that apply to recreational lifters, cyclists, or anyone trying to lose weight.
• Six weeks is one training block. It tells you nothing about how sequencing effects evolve across a full training year, how athletes respond at different training stages, or what happens when accumulated fatigue enters the picture.
• Sport specificity runs deeper than sample size. Even replicating this study in soccer players or wrestlers might produce different results — the performance demands, training stimuli, and measurement protocols are all tuned to judo. The answer to "what helps judo athletes" doesn't reliably generalize, even within combat sports.

Study 2: The Irisin Mouse Model

The second study, published in PLoS One, is a completely different category of science. This is basic mechanistic research in a knockout mouse model. Researchers genetically deleted the FNDC5 gene — which encodes for the hormone irisin — in mice, induced myocardial infarction in those mice, and then had them perform resistance training. Mice lacking irisin showed worse kidney outcomes: more kidney damage in the context of heart-attack-induced cardiorenal syndrome.

This is genuinely interesting mechanistic work. The FNDC5/irisin pathway is worth investigating. The hypothesis that exercise-induced irisin may play a renoprotective role following cardiac injury is a real scientific question. But "worth investigating" and "here's your training protocol" are separated by a very large distance.

Why this is nowhere near a training recommendation

• Knockout mouse models are mechanistic tools, not clinical guides. Genetically deleting a gene in a mouse and observing the downstream effects tells you something about biological pathways — not what healthy humans should do in the gym.
• There is no human data here. No controlled exercise interventions in humans. No irisin measurements at clinical scale. No dose-response data. No protocol. Just a mouse model.
• The clinical context is myocardial infarction-induced cardiorenal syndrome. This is a specific pathological state in an animal model. Even if irisin is protective in this context, that says nothing about irisin's role in healthy people designing their workout programs.
• Translational distance is vast. Most mechanistic findings at this stage never survive the journey to clinical practice. The path from "knockout mice showed worse outcomes" to "here's how to optimize your irisin levels" requires years of follow-up work that doesn't exist yet.

How Bad Science Communication Actually Works

Neither study is doing anything wrong. Both are legitimate research published in real peer-reviewed journals, answering questions they were explicitly designed to answer. The failure happens downstream — in the act of packaging two unrelated findings as a unified recommendation.

The pattern is recognizable once you see it:

1. Find a real RCT, however small or population-specific.
2. Find a mechanistic study with a compelling molecule name — irisin sounds great, very marketable.
3. Build a headline that implies a protocol: "optimal training sequencing + metabolic protection."
4. Let readers connect dots that aren't actually connected.

The judo study says nothing about irisin. The irisin study says nothing about training sequence. The composite "finding" is a narrative assembled from two real data points that both happen to involve exercise.

This is how fitness misinformation spreads — not through fabrication, but through selective framing and deliberately incomplete context. The studies are real. The synthesis is fiction.

What Evidence Would Actually Change Our Minds

On training sequence for general populations:

• Several hundred participants across varied training backgrounds — novice, intermediate, advanced
• Multiple populations: recreational lifters, endurance athletes, clinical populations
• Outcome measures relevant to general audiences, not sport-specific performance metrics
• Replication across different training blocks and time horizons

On irisin's role in human metabolic health:

• Controlled exercise interventions in humans with direct irisin measurement
• Evidence in populations where it might actually matter — cardiac patients, metabolic disease
• Clear dose-response data linking training variables to irisin levels and measurable outcomes

None of that exists in this package. Both may be built eventually — but eventually isn't today, and today isn't a basis for a training recommendation.

The Verdict

Two real studies, zero coherent takeaway. The judo RCT is a small, sport-specific finding that might be worth knowing if you coach competitive judo athletes and want a starting hypothesis for periodization sequencing. The irisin mouse study is early-stage mechanistic work that needs years of follow-up before it becomes relevant to anyone designing a workout. Neither belongs in a recommendation for a general audience, and combining them into one is not science communication — it's brand building dressed up as synthesis.

When someone needs to paste mechanistic mouse data next to an athlete-specific RCT to tell a story, they don't have a story. They have two studies that didn't survive the pitch meeting on their own merits.